Avi Raval is a Managing Director at PJT Partners, focusing on healthcare strategic advisory. His expertise is uniquely shaped by his past experience as the CFO and CBO of Synthego, a genome engineering company, and his education from The Wharton School and the University of Pennsylvania.
He demonstrates a strong interest in the real-world impact of healthcare innovation. Avi is a vocal supporter of policies aimed at improving patient access to advanced treatments like cell and gene therapies, showing a commitment that extends beyond pure financial advisory.
Unique fact: He has operational experience as a C-suite executive at a biotech company, a rare background for a career investment banker.
Avi Raval
Chief Financial and Business Officer at Synthego Corporation
New York, New York, United States
Overview
Topics They Care About
Healthcare M&A
As a Managing Director in PJT's Strategic Advisory group, he has a deep focus on mergers, acquisitions, and strategic transactions within the healthcare industry.
Cell & Gene Therapy
Actively supports policies to improve patient access to these advanced therapies, indicating a professional and personal interest in this cutting-edge field.
Biotech Corporate Strategy
His experience as CFO and CBO at Synthego Corporation provides him with an operator's perspective on financial and business strategy in the biotech space.
Media Appearances
Avi has no verified media appearances
Work History
7-2021
Chief Financial and Business Officer at Synthego Corporation
10-2012 - 7-2021
Managing Director at Perella Weinberg Partners
7-2005 - 10-2012
Executive Director at J.P. Morgan
2000 - 2002
Product Manager at ScreamingMedia
1999 - 2000
Analyst at Mitchell Madison Group
Education
BA from University of Pennsylvania
MBA from The Wharton School
More Information
Social Presence :
Prographics :
Exp : 24
Location : New York, New York, United States
Job Level : Leadership
Designation : Chief Financial and Business Officer at Synthego Corporation
